• Home
  • Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs.

Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs.

Author List
Walz AC, Van De Vyver AJ, Yu L, Birtwistle MR, Krogan NJ, Bouhaddou M
Publication
Pharmacology & therapeutics
Publication ID (Profile URL)
https://researcherprofiles.org/profile/263969748
Publication Year
2022
PubMed ID
35189161
Publication Title
Walz AC, Van De Vyver AJ, Yu L, Birtwistle MR, Krogan NJ, Bouhaddou M. Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs. Pharmacol Ther. 2022 07; 235:108162.